Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter ...

CACI International (CACI) earns a buy rating with strong cashflow growth, cyber focus, and contract wins. Read here for more ...

An Alberta man who’s facing historical human trafficking charges in Nova Scotia must wait nearly a year and a half before his ...

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of ...

Mastercard boosted its guidance for the year, suggesting to one analyst that Visa’s forecast is “overly conservative.” ...

Design and product development platform Figma (FIG) priced its IPO at $33 on Wednesday, which is $1 above the top end of its ...

Meta's strong earnings report sent its stock soaring after hours. The company also made it clear that the AI talent wars come ...

Analysts are expecting Amazon's online stores revenue to increase 6.5% year over year to $58.99 billion, an acceleration from ...

The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...

Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQZ) (the “Company”) today announced the commencement of a registered public offering of notes (the “Notes”). The public ...

Data analytics firm Verisk said on Wednesday it will buy AccuLynx, which makes software for roofing contractors, for $2.35 ...

West Pharmaceutical Services delivered a quarter that outperformed Wall Street’s expectations, reflecting renewed strength in its core high-value product (HVP) components. Management attributed the ...